Literature DB >> 6087206

Alpha-adrenergic receptors in orthostatic hypotension syndromes.

M S Kafka, R J Polinsky, A Williams, I J Kopin, C R Lake, M H Ebert, N S Tokola.   

Abstract

Alpha-adrenergic receptor function was measured in platelets from patients with orthostatic hypotension and normotensive controls. Patients with idiopathic orthostatic hypotension (IOH) or multiple system atrophy (MSA) had more alpha-receptors than controls. Patients with IOH, but not MSA, produced less prostaglandin E1 (PGE1)-stimulated cyclic AMP (cAMP) than controls. Patients with sympathotonic orthostatic hypotension (SOH) were similar to controls in receptor number and cAMP production. The percent norepinephrine (NE) inhibition of PGE1-stimulated cAMP production was similar in patients and controls. An increase in alpha-receptor number may result from decreased peripheral NE secretion in IOH and MSA. Increased alpha-receptor number and decreased cAMP production, which accompany essential hypertension, may contribute to the supine hypertension of IOH, and an increase in alpha-receptor number may contribute to the supine hypertension of MSA. SOH patients appear to have no abnormalities of alpha-receptor function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087206     DOI: 10.1212/wnl.34.8.1121

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Differential effects of beta-adrenoceptor partial agonists in patients with postural hypotension.

Authors:  J Mehlsen; C Stadeager; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  Small fibre function in primary autonomic failure.

Authors:  R Baron; R Feldmann; V Lindner
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

Review 3.  Modelling progressive autonomic failure in MSA: where are we now?

Authors:  Sylvia Stemberger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.